Prescription Opioid Use and Abuse in the Treatment of Pain (R01, R03, R21, R25)
The summary for the Prescription Opioid Use and Abuse in the Treatment of Pain (R01, R03, R21, R25) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Prescription Opioid Use and Abuse in the Treatment of Pain (R01, R03, R21, R25): - Problem to be addressed: The most powerful treatments available for most forms of pain are opioids. However, opioid treatment can produce negative health consequences, such as intoxication and physical dependence, and may result in opioid abuse and addiction. The prevalence, and how to prevent, reduce, and treat these negative health consequences of opioid administration in the context of pain are not well understood. - This Request for Applications (RFA) solicits new applications that examine risk and protective factors regarding the onset of opioid abuse and addiction in the context of pain, develop pain treatment protocols that are tailored to reduce the probability of these negative health consequences, and develop ways to ameliorate these problems when they occur. - The overall goal of this RFA is to provide a scientific foundation that can help inform health care providers on how to treat pain successfully while minimizing the risks of abuse and addiction to opioids.
| Federal Grant Title: | Prescription Opioid Use and Abuse in the Treatment of Pain (R01, R03, R21, R25) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health Education |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-DA-06-005 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.12193.279 |
| CFDA Descriptions: | Oral Diseases and Disorders Research 93.279 Drug Abuse Research Programs |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Feb 23, 2006 |
| Posted Date: | Nov 18, 2005 |
| Creation Date: | Nov 18, 2005 |
| Archive Date: | Mar 25, 2006 |
| Total Program Funding: | $5,700,000 |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | 93.866 -- Aging Research |
- Applicants Eligible for this Grant
- County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) State governments
- Additional Information on Eligibility
- Eligible agencies of the Federal government are eligible to apply Foreign applications will be accepted, provided that they meet the eligibility requirements and standard regulations/policies prescribed for foreign applicants. You may submit an R25 application if your organization meets the following characteristics: Public or private U.S. dental schools. Foreign institutions are not eligible to apply for an R25 award.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email [email protected] [email protected] Webmaster, NIH